Work

Supplementary Figure Legends 1-2 from BRAF(V600) Inhibitor GSK2118436 Targeted Inhibition of Mutant BRAF in Cancer Patients Does Not Impair Overall Immune Competency

Year: 2023

Type: supplementary-materials

DOI: 10.1158/1078-0432.22444185.v1

Authors: David S. Hong, Luis Vence, Gerald Falchook, Laszlo G. Radvanyi, Chengwen Liu, Vicki Goodman, Jeffery J. Legos, Sam Blackman, Antonio Scarmadio, Razelle Kurzrock, Gregory Lizee, Patrick Hwu

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362430270

Cites:

Cited by:

Related to: 10